STVN
Stevanato Group S.p.A.
STVN offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over STVN overall, supported by lower modeled downside and stronger modeled upside.
STVN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Healthy |
STVN's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
STVN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 27x | $14.36 | — |
| Cheap | 31x | $16.55 | +15% |
| Fair | 39x | $20.56 | +43% |
| Expensive | 49x | $25.80 | +80% |
Historical ranges are pointers, not guarantees.
STVN has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
STVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect STVN's earnings to grow and its profitability to improve, with its revenue holding steady.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
STVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.53 | -5.4% |
| Q1 2026 | $0.57 | +9.6% |
| Q4 2025 | $0.57 | +16% |
| Q3 2025 | $0.58 | +23% |
| Q2 2025 | $0.56 | +7.7% |
| Q1 2025 | $0.52 | -10% |
| Q4 2024 | $0.49 | -21% |
| Q3 2024 | $0.47 | -24% |
STVN has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
STVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $335.5M | +7.8% |
| Q1 2026 | $303.9M | +6.6% |
| Q4 2025 | $381.3M | +3.8% |
| Q3 2025 | $336.8M | +9.1% |
| Q2 2025 | $311.1M | +7.9% |
| Q1 2025 | $285.1M | +8.7% |
| Q4 2024 | $367.3M | +3.1% |
| Q3 2024 | $308.7M | +2.4% |
STVN's revenue has grown year over year for nine quarters in a row: $335M last quarter, up 7.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | -1.8 points |
| Q1 2026 | 14% | +0.7 points |
| Q4 2025 | 19% | -1 points |
| Q3 2025 | 17% | +2.6 points |
| Q2 2025 | 15% | +4 points |
| Q1 2025 | 14% | +2.8 points |
| Q4 2024 | 20% | +0.3 points |
| Q3 2024 | 15% | -4.1 points |
STVN has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
STVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$37.6M | -$20.6M |
| Q1 2026 | $5.3M | -83% |
| Q4 2025 | $5.2M | +$55.4M |
| Q3 2025 | -$1.3M | +$121.2M |
| Q2 2025 | -$17.1M | +$34.6M |
| Q1 2025 | $31.2M | +$65.7M |
| Q4 2024 | -$50.3M | +$35.2M |
| Q3 2024 | -$122.5M | +$166.1M |
STVN has burned cash in most quarters: −$28M over the past year, against −$159M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over STVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
STVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -21.1K shares |
| 1 year | 0% | +77K shares |
| 3 years | +2.9% | +7.6M shares |
| 5 years | -9.1% | -27.4M shares |
| Available history | -7.4% | -21.8M shares |
STVN has 273M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
STVN hasn't bought back shares in the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over STVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
STVN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 1.1x | Healthy |
| Q3 2024 | 1.0x | Healthy |
STVN has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
STVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.2 | Neutral |
| Stochastic | 17.5 | Oversold |
STVN's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
STVN PE vs Healthcare Sector
| Metric | STVN | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 26x | 4.2% above |
| PE % | 6 | 38 | 32 pts below |
STVN is trading at 27x earnings, in line with the Healthcare sector's median of 26x, though its earnings don't support one.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over STVN on valuation relative to its sector.
STVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.3 | 22% below |
| 20 week MA | $19.6 | 27% below |
| 50 week MA | $18.2 | 21% below |
| 100 week MA | $20.7 | 30% below |
| 200 week MA | $23.1 | 38% below |
STVN is in a downtrend: it's below all five of its weekly moving averages, and 38% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over STVN on trend strength, trading above more of its moving averages.
STVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.7 | $23.3 | +19% |
| 2022 | $23.3 | $17.9 | -23% |
| 2023 | $17.9 | $27.3 | +53% |
| 2024 | $27.3 | $21.6 | -21% |
| 2025 | $21.6 | $20.7 | -4.2% |
| 2026 YTD | $20.7 | $14.4 | -31% |
STVN has finished lower in three of the last five years. It's down 31% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over STVN on returns for 2026, with the stronger performance.